2
|
Guillot C, Pelletier J, Aenishaenslin C, Coatsworth H, Dibernardo A, Koffi JK, Kulkarni MA, Rocheleau JP, Wilson C, Russell C, Nelder MP, Badcock J, Carr J, Checkley S, Clow KM, Cooper S, Cork S, Dumas A, Dergousoff S, Faraone N, Fraser E, Graham-Derham S, Irace-Cima A, Iwasawa S, Jenkins E, Leighton PA, McKay R, Morshed M, Pelletier R, Ripoche M, Rochon K, Thivierge K, Voordouw MJ, Ogden NH, Bouchard C. The distribution of Babesia odocoilei in Ixodes species ticks in Canada: Implications for one health surveillance. Ticks Tick Borne Dis 2024; 15:102413. [PMID: 39571507 DOI: 10.1016/j.ttbdis.2024.102413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Revised: 10/25/2024] [Accepted: 11/09/2024] [Indexed: 12/17/2024]
Abstract
Ixodes scapularis and Ixodes pacificus are vectors of a range of pathogens of public health significance in North America. These ticks transmit pathogens to and from wild animal reservoir host species, but also bite humans and expose them to the pathogens. We describe the geographical and temporal distribution of the pathogen Babesia odocoilei, the causative agent of cervid babesiosis. Ixodes spp. ticks collected through active and passive surveillance were submitted to the National Microbiology Laboratory of the Public Health Agency of Canada for analysis of the presence of B. odocoilei from 2018 to 2021. Generalized linear models were constructed to evaluate the temporal change of B. odocoilei prevalence across Canada. Babesia odocoilei-positive I. scapularis are widespread across south-central and eastern regions of Canada, with an overall prevalence of 12.0 % in both nymphs (CI 95 % : 11.4-12.6) and adults (CI 95 % : 11.9-12.1) collected in passive surveillance and 13.2 % (CI 95 % : 12.9-13.5) and 10.0 % (CI 95 % : 9.8-10.2) in nymphs and adult, respectively, collected in active surveillance. A single I. pacificus tick tested positive in active surveillance out of 29 ticks collected in British Columbia, while no B odocoilei-positive I. scapularis were found in passive surveillance among the 11 adult ticks tested. Although B. odocoilei infection prevalence of adult I. scapularis was significantly higher in 2019 (14.1 %) than in 2018 (7.4 %), it remained stable from 2019 to 2021, suggesting that this pathogen may already be well established in endemic tick populations. The results provided in this article represent, to date, the most comprehensive picture of B. odocoilei distribution and prevalence in ticks in Canada and highlight the interest of maintaining One Health surveillance approaches to give added insight into disease transmission cycles for less well-characterized microorganisms.
Collapse
Affiliation(s)
- Camille Guillot
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Centre de recherche en santé publique de l'Université de Montréal et CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Université de Montréal, Montréal, Canada.
| | - Jérôme Pelletier
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Centre de recherche en santé publique de l'Université de Montréal et CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Université de Montréal, Montréal, Canada
| | - Cécile Aenishaenslin
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Centre de recherche en santé publique de l'Université de Montréal et CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Université de Montréal, Montréal, Canada
| | - Heather Coatsworth
- Mycobacteriology, Vector-borne and Prion Diseases Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
| | - Antonia Dibernardo
- Mycobacteriology, Vector-borne and Prion Diseases Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
| | - Jules K Koffi
- Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Ottawa, Ontario, Canada
| | - Manisha A Kulkarni
- School of Epidemiology & Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - Jean-Philippe Rocheleau
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Département de santé animale, Cégep de Saint-Hyacinthe, Saint-Hyacinthe, Québec, Canada
| | - Christy Wilson
- Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Ottawa, Ontario, Canada
| | - Curtis Russell
- Enteric, Zoonotic and Vector-Borne Diseases, Health Protection, Public Health Ontario, Toronto, Ontario, Canada
| | - Mark P Nelder
- Enteric, Zoonotic and Vector-Borne Diseases, Health Protection, Public Health Ontario, Toronto, Ontario, Canada
| | - Jacqueline Badcock
- New Brunswick Department of Health, Government of New Brunswick, Fredericton, New Brunswick, Canada
| | - Justin Carr
- Provincial Veterinary Laboratory, Department of Agriculture, Aquaculture, and Fisheries, New Brunswick, Canada
| | - Sylvia Checkley
- Faculty of Veterinary Medicine, University of Calgary, Alberta, Canada
| | - Katie M Clow
- Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada
| | - Stephanie Cooper
- Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada
| | - Susan Cork
- Faculty of Veterinary Medicine, University of Calgary, Alberta, Canada
| | - Ariane Dumas
- Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, Québec, Canada
| | - Shaun Dergousoff
- Lethbridge Research and Development Centre, Agriculture and Agri-Food Canada, Lethbridge, Alberta, Canada
| | - Nicoletta Faraone
- Chemistry Department, Acadia University, Wolfville, Nova Scotia, Canada
| | - Erin Fraser
- Communicable Disease and Immunization Service, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
| | - Scott Graham-Derham
- Department of Education and Early Childhood Learning, Government of Manitoba, Winnipeg, Manitoba, Canada
| | - Alejandra Irace-Cima
- Direction des risques biologiques, Institut national de santé publique du Québec, Montréal, Québec, Canada
| | - Stefan Iwasawa
- Communicable Disease and Immunization Service, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; Centre for Coastal Health, Nanaimo, British Columbia, Canada
| | - Emily Jenkins
- Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
| | - Patrick A Leighton
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Centre de recherche en santé publique de l'Université de Montréal et CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Université de Montréal, Montréal, Canada
| | - Roman McKay
- School of Epidemiology & Public Health, University of Ottawa, Ottawa, Ontario, Canada
| | - Muhammad Morshed
- BCCDC Public Health Laboratory, Vancouver, British Columbia, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Roxane Pelletier
- Direction des risques biologiques, Institut national de santé publique du Québec, Montréal, Québec, Canada
| | - Marion Ripoche
- Direction des risques biologiques, Institut national de santé publique du Québec, Montréal, Québec, Canada
| | - Kateryn Rochon
- Department of Entomology, Faculty of Agricultural and Food Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Karine Thivierge
- Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada; Institute of Parasitology, Faculty of Agricultural and Environmental Sciences, McGill University, Sainte-Anne-de-Bellevue, Québec, Canada
| | - Maarten J Voordouw
- Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
| | - Nicholas H Ogden
- Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, Québec, Canada
| | - Catherine Bouchard
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada; Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, Québec, Canada
| |
Collapse
|
3
|
Armstrong BA, Brandt KS, Goodrich I, Gilmore RD. Evaluation of Immunocompetent Mouse Models for Borrelia miyamotoi Infection. Microbiol Spectr 2023; 11:e0430122. [PMID: 36715531 PMCID: PMC10100797 DOI: 10.1128/spectrum.04301-22] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Accepted: 01/10/2023] [Indexed: 01/31/2023] Open
Abstract
Borrelia miyamotoi is a relapsing fever spirochete that is harbored by Ixodes spp. ticks and is virtually uncharacterized, compared to other relapsing fever Borrelia vectored by Ornithodoros spp. ticks. There is not an immunocompetent mouse model for studying B. miyamotoi infection in vivo or for transmission in the vector-host cycle. Our goal was to evaluate B. miyamotoi infections in multiple mouse breeds/strains as a prelude to the ascertainment of the best experimental infection model. Two B. miyamotoi strains, namely, LB-2001 and CT13-2396, as well as three mouse models, namely, CD-1, C3H/HeJ, and BALB/c, were evaluated. We were unable to observe B. miyamotoi LB-2001 spirochetes in the blood via darkfield microscopy or to detect DNA via real-time PCR post needle inoculation in the CD-1 and C3H/HeJ mice. However, LB-2001 DNA was detected via real-time PCR in the blood of the BALB/c mice after needle inoculation, although spirochetes were not observed via microscopy. CD-1, C3H/HeJ, and BALB/c mice generated an antibody response to B. miyamotoi LB-2001 following needle inoculation, but established infections were not detected, and the I. scapularis larvae failed to acquire spirochetes from the exposed CD-1 mice. In contrast, B. miyamotoi CT13-2396 was visualized in the blood of the CD-1 and C3H/HeJ mice via darkfield microscopy and detected by real-time PCR post needle inoculation. Both mouse strains seroconverted. However, no established infection was detected in the mouse organs, and the I. scapularis larvae failed to acquire Borrelia after feeding on CT13-2396 exposed CD-1 or C3H/HeJ mice. These findings underscore the challenges in establishing an experimental B. miyamotoi infection model in immunocompetent laboratory mice. IMPORTANCE Borrelia miyamotoi is a causative agent of hard tick relapsing fever, was first identified in the early 1990s, and was characterized as a human pathogen in 2011. Unlike other relapsing fever Borrelia species, B. miyamotoi spread by means of Ixodes ticks. The relatively recent recognition of this human pathogen means that B. miyamotoi is virtually uncharacterized, compared to other Borrelia species. Currently there is no standard mouse-tick model with which to study the interactions of the pathogen within its vector and hosts. We evaluated two B. miyamotoi isolates and three immunocompetent mouse models to identify an appropriate model with which to study tick-host-pathogen interactions. With the increased prevalence of human exposure to Ixodes ticks, having an appropriate model with which to study B. miyamotoi will be critical for the future development of diagnostics and intervention strategies.
Collapse
Affiliation(s)
- Brittany A. Armstrong
- Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
| | - Kevin S. Brandt
- Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
| | - Irina Goodrich
- Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
| | - Robert D. Gilmore
- Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
| |
Collapse
|